Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2005

01-07-2005 | Brief Report

Unexpected high prevalence of hepatitis B and HIV infections in Malian medical students

Authors: I. Maïga, A. Le Faou, C. P. Muller, V. Venard

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2005

Login to get access

Excerpt

Hepatitis B virus (HBV) persistently infects 350 million people worldwide. In particular, sub-Saharan Africa and Southeast Asia sustain a high level of endemicity. In the study reported here, 152 sera were obtained on a voluntary basis from 152 healthy students of the Faculty of Medicine at the University of Bamako, Mali, for hepatitis B diagnosis and HIV serological testing. Among these students, 128 (84%) were found to have evidence of HBV contact, as determined by total antibodies to the HBV core antigen (anti-HBc), and 84 (55%) of them were also positive for HBsAg (AXSYM core, AXSYM HBs Ag V2; Abbott Laboratories, Rungis, France). DNA-positive results (>200 copies/ml, Cobas Amplicor HBV Monitor test; Roche Diagnostics, Meylan, France) were obtained for 38 of the 152 (25%) sera. Two sera with low copy numbers of DNA (222 and 270 copies/ml) were HBsAg negative, bringing the number of chronically infected individuals to 86 (57%). …
Literature
1.
go back to reference Odemuyiwa SO, Mulders MN, Oyedele OI, Ola SO, Odaibo GN, Olaleye DO, Muller CP (2001) Phylogenetic analysis of new hepatitis B virus isolates from Nigeria supports endemicity of genotype E in West Africa. J Med Virol 65:463–469CrossRefPubMed Odemuyiwa SO, Mulders MN, Oyedele OI, Ola SO, Odaibo GN, Olaleye DO, Muller CP (2001) Phylogenetic analysis of new hepatitis B virus isolates from Nigeria supports endemicity of genotype E in West Africa. J Med Virol 65:463–469CrossRefPubMed
2.
go back to reference Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO, Kehinde MO, Muyembe Tamfum JJ, Nébie YK, Maïga I, Ammerlaan W, Fack F, Omilabu SA, Le Faou A, Muller CP (2004) Low genetic diversity despite hyperendemicity of hepatitis B genotype E throughout Western Africa. J Infect Dis 190:400–408CrossRefPubMed Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO, Kehinde MO, Muyembe Tamfum JJ, Nébie YK, Maïga I, Ammerlaan W, Fack F, Omilabu SA, Le Faou A, Muller CP (2004) Low genetic diversity despite hyperendemicity of hepatitis B genotype E throughout Western Africa. J Infect Dis 190:400–408CrossRefPubMed
3.
go back to reference Lienhardt C, Kamate B, Jamet P, Tounkara A, Faye OC, Sow SO, Bobin P (1996) Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali. Int J Lepr Other Mycobact Dis 64:383–391PubMed Lienhardt C, Kamate B, Jamet P, Tounkara A, Faye OC, Sow SO, Bobin P (1996) Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali. Int J Lepr Other Mycobact Dis 64:383–391PubMed
4.
go back to reference Maïga MK, Traore S, Guindo A, Fofana O (1989) Control of HIV transmission in the national blood bank in Mali. In: Program and abstracts of the 5th International AIDS Conferences. Abstract A.577 Maïga MK, Traore S, Guindo A, Fofana O (1989) Control of HIV transmission in the national blood bank in Mali. In: Program and abstracts of the 5th International AIDS Conferences. Abstract A.577
5.
go back to reference Boerma JT, Ghys PD, Walker N (2003) Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard. Lancet 362:1929–1931CrossRefPubMed Boerma JT, Ghys PD, Walker N (2003) Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard. Lancet 362:1929–1931CrossRefPubMed
6.
go back to reference Sibide S, Sacko BY, Traore I (2001) Prevalence of serologic markers of the hepatitis B virus in pregnant women of Bamako, Mali. Bull Soc Pathol Exot 94:339–341PubMed Sibide S, Sacko BY, Traore I (2001) Prevalence of serologic markers of the hepatitis B virus in pregnant women of Bamako, Mali. Bull Soc Pathol Exot 94:339–341PubMed
Metadata
Title
Unexpected high prevalence of hepatitis B and HIV infections in Malian medical students
Authors
I. Maïga
A. Le Faou
C. P. Muller
V. Venard
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-005-1359-x

Other articles of this Issue 7/2005

European Journal of Clinical Microbiology & Infectious Diseases 7/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.